SRTS (Sensus Healthcare) Float Percentage Of Total Shares Outstanding: 89.96% (As of Jun. 30, 2026)


SRTS Sensus Healthcare Inc SRTS
74 GF Score
Price $3.02
GF Value $2.85
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sensus Healthcare Float Percentage Of Total Shares Outstanding?

Sensus Healthcare SRTS -1.63% 74 Float Percentage Of Total Shares Outstanding is 89.96% as of Jun. 30, 2026. GuruFocus rates SRTS with a GF Score™ of 74/100 and a GF Value™ of $2.85 (Fairly Valued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sensus Healthcare's float shares is 14.81 Mil. Sensus Healthcare's total shares outstanding is 16.46 Mil. Sensus Healthcare's float percentage of total shares outstanding is 89.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sensus Healthcare's Insider Ownership is 29.12%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sensus Healthcare's Institutional Ownership is 29.18%.

SRTS
74GF Score
Sensus Healthcare Inc SRTS
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensus Healthcare Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sensus Healthcare's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=14.81/16.46
=89.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 89.96% mean?
Sensus Healthcare (SRTS) has a Float Percentage Of Total Shares Outstanding of 89.96% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sensus Healthcare and its competitors.
Is Sensus Healthcare's Float Percentage Of Total Shares Outstanding too high?
Sensus Healthcare's current Float Percentage Of Total Shares Outstanding is 89.96%. Overall, Sensus Healthcare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sensus Healthcare's Float Percentage Of Total Shares Outstanding compare to COCH and QTI?
Sensus Healthcare's Float Percentage Of Total Shares Outstanding of 89.96% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sensus Healthcare and its competitors. Sensus Healthcare's current Float Percentage Of Total Shares Outstanding is 89.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sensus Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sensus Healthcare (SRTS) is currently considered Fairly Valued. The stock's GF Value™ is $2.85, compared to a current price of $3.02 — trading 6% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 89.96%. Sensus Healthcare's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sensus Healthcare (SRTS), the current Float Percentage Of Total Shares Outstanding is 89.96% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sensus Healthcare (SRTS) Overvalued in 2026?

Based on GuruFocus' analysis, Sensus Healthcare stock appears to be overvalued. The current stock price of $3.02 is trading 6% above its estimated GF Value™ of $2.85. GuruFocus considers Sensus Healthcare to be Fairly Valued.

Key valuation signals for SRTS:

  • Float Percentage Of Total Shares Outstanding: 89.96%
  • GF Value™: $2.85 vs. price of $3.02 (6% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the SRTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensus Healthcare Business Description

Other Exchanges 5TX:Germany
Address 851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
74GF Score

Get the complete analysis for SRTS

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.02
Price
$2.85
GF Value